Cite
HARVARD Citation
Montez-Rath, M. et al. (2022). Characterizing real world safety profile of oral Janus kinase inhibitors among adult atopic dermatitis patients: evidence transporting from the rheumatoid arthritis population. Current medical research and opinion. pp. 1431-1437. [Online].